Jiachang Chi

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Ahmed O. Kaseb, Xingxing Qi et al. · Clinical Cancer Research · 2020 · 340 citations

A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC).

Bo Zhai, Donghua Shi, Huiping Gao et al. · Journal of Clinical Oncology · 2017 · 82 citations

Cell Therapy, Immunology, Pathology +18

Risk Assessment and Hydrodissection Technique for Radiofrequency Ablation of Thyroid Benign Nodules

Tang Xiaoyin, Ping Li, Dan Cui et al. · Journal of Cancer · 2018 · 60 citations · Full text

HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients

Jing Zou, Qiang Guo, Jiachang Chi et al. · Clinical Rheumatology · 2015 · 58 citations

1-Year Mortality, Serum Ferritin Level, Pulmonary Fibrosis +2

Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients

Tao Wang, Xiaojie Lu, Jiachang Chi et al. · Scientific Reports · 2016 · 38 citations · Full text